Keytruda.
metastatic melanoma or inoperable cases of this skin tumor;
non-small cell lung cancer, especially metastatic, having a high expression (manifestation) of the target receptor;
metastatic non-squamous non-small cell lung cancer in combination with chemotherapeutic agents;
recurrent and metastatic squamous cell carcinoma of the head and neck;
kidney cancer, including metastatic, with the ineffectiveness of chemotherapy;
inoperable or metastatic cancer of the internal organs with the ineffectiveness of chemotherapy;
gastric cancer, adenocarcinoma of the esophagus.
Active ingredient: pembrolizumab
Storage temperature 4-8 degrees
Prescription medicine.